Found: 76
Select item for more details and to access through your institution.
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08120-8
- By:
- Publication type:
- Article
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 11, p. 1, doi. 10.1007/s00520-023-08120-8
- By:
- Publication type:
- Article
Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross‐sectional survey.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1262, doi. 10.1111/bjh.19307
- By:
- Publication type:
- Article
Lenalidomide plus rituximab (R<sup>2</sup>) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 874, doi. 10.1111/bjh.15843
- By:
- Publication type:
- Article
Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 670, doi. 10.1111/bjh.15814
- By:
- Publication type:
- Article
Stage I Non‐Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 334, doi. 10.1111/bjh.15444
- By:
- Publication type:
- Article
Post‐ABVD biopsy results, and not post‐ABVD FDG‐PET results, predict outcome in early‐stage Hodgkin lymphoma: response to Adams and Kwee.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 2, p. 292, doi. 10.1111/bjh.15072
- By:
- Publication type:
- Article
Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 4, p. 545, doi. 10.1111/bjh.15054
- By:
- Publication type:
- Article
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 851, doi. 10.1111/bjh.14267
- By:
- Publication type:
- Article
Dose adjusted- EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 503, doi. 10.1111/bjh.14226
- By:
- Publication type:
- Article
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 488, doi. 10.1111/bjh.14902
- By:
- Publication type:
- Article
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R- FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 263, doi. 10.1111/bjh.14541
- By:
- Publication type:
- Article
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 750, doi. 10.1111/bjh.14477
- By:
- Publication type:
- Article
Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 531, doi. 10.1111/bjh.13863
- By:
- Publication type:
- Article
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 2, p. 290, doi. 10.1111/bjh.14237
- By:
- Publication type:
- Article
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 726, doi. 10.1111/bjh.13659
- By:
- Publication type:
- Article
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 463, doi. 10.1111/bjh.13603
- By:
- Publication type:
- Article
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 509, doi. 10.1111/bjh.13628
- By:
- Publication type:
- Article
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 814, doi. 10.1111/bjh.13367
- By:
- Publication type:
- Article
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 5, p. 689, doi. 10.1111/bjh.13349
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 207, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 177, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 6, p. 891, doi. 10.1111/bjh.12982
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 891, doi. 10.1111/bjh.12982
- By:
- Publication type:
- Article
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 112, doi. 10.1111/bjh.12715
- By:
- Publication type:
- Article
Phase IA/ II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non- Hodgkin or Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 2, p. 258, doi. 10.1111/bjh.12630
- By:
- Publication type:
- Article
Prospective phase II study of rituximab with alternating cycles of hyper- CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 611, doi. 10.1111/bjh.12585
- By:
- Publication type:
- Article
Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 2, p. 335, doi. 10.1007/s00277-021-04692-9
- By:
- Publication type:
- Article
Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
- Published in:
- 2019
- By:
- Publication type:
- journal article
(P110) Hodgkin Lymphoma and Pregnancy: Treatment Patterns and Survival Outcomes of Women Treated With Modern Chemotherapy and Radiotherapy.
- Published in:
- Oncology (08909091), 2015, v. 29, p. 1
- By:
- Publication type:
- Article
The Effect of Zoledronic Acid on the Prevention of Bone Loss in Lymphoma Patients Receiving First-line Therapy.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. E30, doi. 10.3816/CLM.2009.n.092
- By:
- Publication type:
- Article
Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 147, n. 1, p. 1, doi. 10.1007/s10549-014-3034-3
- By:
- Publication type:
- Article
Monoclonal Antibodies in the Treatment of Non-Hodgkin's Lymphoma.
- Published in:
- Drugs, 2007, v. 67, n. 3, p. 333, doi. 10.2165/00003495-200767030-00002
- By:
- Publication type:
- Article
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 99, doi. 10.1016/j.clml.2012.11.002
- By:
- Publication type:
- Article
Bone Loss in Lymphoma Patients Prior to Receiving Front-line Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E32, doi. 10.3816/CLML.2010.n.042
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 2, p. e21, doi. 10.1016/j.clml.2023.10.001
- By:
- Publication type:
- Article
Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 527, doi. 10.1016/j.clml.2023.03.015
- By:
- Publication type:
- Article
ABCL-454: CheckMate 436: Extended Follow-Up from the Phase 2 Study Investigating Nivolumab Plus Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S398, doi. 10.1016/S2152-2650(21)01901-7
- By:
- Publication type:
- Article
Poster: ABCL-454: CheckMate 436: Extended Follow-Up from the Phase 2 Study Investigating Nivolumab Plus Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S242, doi. 10.1016/S2152-2650(21)01520-2
- By:
- Publication type:
- Article
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
New Strategies for the Treatment of Early Stage Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S153, doi. 10.1016/j.clml.2017.08.071
- By:
- Publication type:
- Article
Deeper Insights Into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article